Rachel Millner
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Associate Professor
Also affiliated: Arkansas Children's Hospital (2018–2023); Nationwide Children's Hospital (2019); University of Arkansas Medical Center (2023); University of Vermont Children’s Hospital (2015); University of Iowa Stead Family Children’s Hospital (2023); University of Applied Management Studies (2020)
Faculty Researcher
Peds Pediatrics, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Rachel Millner's research focuses on pediatric nephrology and related conditions, with recent work examining the impact of COVID-19 vaccination on new-onset glomerular disease through the IRocGN2 International Registry. Her publications also address the utilization patterns of eculizumab for children with hemolytic uremic syndrome and explore the development of quality improvement training within pediatric residency programs. Millner has contributed to reviews on preparing pediatric patients with advanced chronic kidney disease for kidney replacement therapy, emphasizing multidisciplinary clinical approaches to patient and caregiver education.
Her work also touches on broader health topics, including an examination of anti-fat bias in psychotherapies for eating disorders and the diagnosis of systemic lupus erythematosus. Millner's scholarship metrics include an h-index of 5 with 320 citations across 13 publications. She collaborates with several researchers at the University of Arkansas for Medical Sciences, including Saritha Ranabothu and Brendan Crawford, with whom she shares multiple publications.
Metrics
- h-index: 5
- Publications: 13
- Citations: 324
Selected Publications
-
Creating a Roadmap for Longitudinal Quality Improvement Training in a Pediatric Residency Program (2025)
-
Moving the neonatal nephrology field forward: results from the Pediatric Academic Society Neonatal Nephrology Focus Group (2023)
-
Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education (2023)
-
COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry (2022)
-
Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome (2021)
-
Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series (2020)
Collaboration Network
Top Collaborators
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education
- Preparing for kidney replacement therapy in pediatric advanced CKD: a review of literature and defining a multi-disciplinary clinical approach to patient-caregiver education
- Moving the neonatal nephrology field forward: results from the Pediatric Academic Society Neonatal Nephrology Focus Group
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
- COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
Similar Researchers
Based on overlapping research topics